These deflation plays are favored amid European chemicals sector challenges

Belgium's Solvay cut its annual core earnings guidance to €880-930 million from a prior €1.0-1.1 billion, attributing the reduction to a soft market, global tariff discussions, and geopolitical tensions that have curtailed demand and slowed order books. This revision underscores broader pressures on the European chemicals sector, with analysts noting that aggressive U.S. tariffs are indirectly impacting exports and redirecting excess Chinese production to Europe, intensifying price and margin competition. The industry faces a challenging outlook for 2025, with risks of price reductions that could unwind post-COVID margin gains, though some downstream chemical companies may see potential benefits.

Analysis

Belgium's Solvay has materially revised its 2025 core earnings guidance downwards to between €880 million and €930 million, a significant reduction from the previously anticipated €1.0 billion to €1.1 billion. The company attributes this cut to a deteriorating market environment in the second quarter, characterized by soft demand, a slowdown in order books, and low visibility, all of which are exacerbated by ongoing global tariff discussions and heightened geopolitical tensions. This event is symptomatic of broader headwinds facing the European chemicals sector. Analyst commentary from ING highlights a dual-pronged pressure: indirect impacts from U.S. tariffs are denting exports for industries that consume chemicals, while excess Chinese chemical production, diverted to Europe, is actively compressing regional sales prices and margins. Morgan Stanley corroborates this pessimistic outlook, anticipating a downbeat Q2 earnings season across the sector due to these supply chain and tariff-related struggles. While a rebound in demand could occur if supply chains normalize, a key risk remains that widespread price cuts in 2025 could erode the substantial margin gains achieved in the post-COVID period, signaling intensified competition. This dynamic could potentially benefit downstream producers, though this is not a guaranteed outcome.

Key Decisions for Investors

• Investors should exercise caution with exposure to European upstream chemical producers, as Solvay's guidance cut signals significant sector-wide pressure on demand and margins from tariffs and Chinese oversupply.
• Monitor upcoming Q2 earnings reports from other European chemical companies for corroboration of these negative trends, paying close attention to management commentary on order books, pricing power, and supply chain stability.
• Consider a relative value analysis between upstream producers facing margin compression and downstream chemical companies like Akzo Nobel and Syensqo, which could potentially benefit from lower input costs, while remaining aware that intense competition could eventually erode their margins too.
• Watch for macroeconomic catalysts, such as a normalization of supply chains or de-escalation of trade disputes, which analysts identify as potential triggers for a sharp demand rebound and a revised sector outlook.